Literature DB >> 20660752

Myocytic androgen receptor controls the strength but not the mass of limb muscles.

Céline Chambon1, Delphine Duteil, Alban Vignaud, Arnaud Ferry, Nadia Messaddeq, Rocco Malivindi, Shigeaki Kato, Pierre Chambon, Daniel Metzger.   

Abstract

The anabolic effects of androgens on skeletal muscles are thought to be mediated predominantly through the androgen receptor (AR), a member of the ligand-dependent nuclear receptor superfamily. However, despite numerous studies performed in men and in rodents, these effects remain poorly understood. To characterize androgen signaling in skeletal muscles, we generated mice in which the AR is selectively ablated in myofibers. We show that myocytic AR controls androgen-induced insulin-like growth factor IEa (IGF-IEa) expression in the highly androgen-sensitive perineal muscles and that it mediates androgen-stimulated postnatal hypertrophy of these muscles. In contrast, androgen-dependent postnatal hypertrophy of limb muscle fibers is independent of myocytic AR. Thus, androgens control perineal and limb muscle mass in male mice through myocytic AR-dependent and -independent pathways, respectively. Importantly, we also show that AR deficiency in limb myocytes impairs myofibrillar organization of sarcomeres and decreases muscle strength, thus demonstrating that myocytic AR controls key pathways required for maximum force production. These distinct androgen signaling pathways in perineal and limb muscles may allow the design of screens to identify selective androgen modulators of muscle strength.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660752      PMCID: PMC2922552          DOI: 10.1073/pnas.1009536107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Experience with testosterone replacement in the elderly.

Authors:  J L Tenover
Journal:  Mayo Clin Proc       Date:  2000-01       Impact factor: 7.616

2.  Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.

Authors:  C Wang; D R Eyre; R Clark; D Kleinberg; C Newman; A Iranmanesh; J Veldhuis; R E Dudley; N Berman; T Davidson; T J Barstow; R Sinow; G Alexander; R S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

3.  Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.

Authors:  S Bhasin; T W Storer; M Javanbakht; N Berman; K E Yarasheski; J Phillips; M Dike; I Sinha-Hikim; R Shen; R D Hays; G Beall
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

4.  Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

Authors:  C Wang; R S Swerdloff; A Iranmanesh; A Dobs; P J Snyder; G Cunningham; A M Matsumoto; T Weber; N Berman
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

5.  Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I.

Authors:  Amelia Entingh-Pearsall; C Ronald Kahn
Journal:  J Biol Chem       Date:  2004-07-07       Impact factor: 5.157

6.  Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study.

Authors:  I G Brodsky; P Balagopal; K S Nair
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

7.  Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuromuscular junction.

Authors:  Douglas Ashley Monks; Erin Louise O'Bryant; Cynthia Lee Jordan
Journal:  J Comp Neurol       Date:  2004-05-17       Impact factor: 3.215

8.  Testosterone therapy in glucocorticoid-treated men.

Authors:  I R Reid; D J Wattie; M C Evans; J P Stapleton
Journal:  Arch Intern Med       Date:  1996-06-10

9.  Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis.

Authors:  R J Urban; Y H Bodenburg; C Gilkison; J Foxworth; A R Coggan; R R Wolfe; A Ferrando
Journal:  Am J Physiol       Date:  1995-11

10.  Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle.

Authors:  Sophie Nicole; Benedicte Desforges; Gaelle Millet; Jeanne Lesbordes; Carmen Cifuentes-Diaz; Dora Vertes; My Linh Cao; Fabienne De Backer; Laetitia Languille; Natacha Roblot; Vandana Joshi; Jean-Marie Gillis; Judith Melki
Journal:  J Cell Biol       Date:  2003-05-12       Impact factor: 10.539

View more
  34 in total

Review 1.  Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions.

Authors:  Vanessa Dubois; Michaël Laurent; Steven Boonen; Dirk Vanderschueren; Frank Claessens
Journal:  Cell Mol Life Sci       Date:  2011-11-19       Impact factor: 9.261

2.  Preparing to migrate: expression of androgen signaling molecules and insulin-like growth factor-1 in skeletal muscles of Gambel's white-crowned sparrows.

Authors:  Devaleena S Pradhan; Chunqi Ma; Barney A Schlinger; Kiran K Soma; Marilyn Ramenofsky
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2018-12-08       Impact factor: 1.836

Review 3.  Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis.

Authors:  Thomas Braun; Mathias Gautel
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06       Impact factor: 94.444

4.  Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development.

Authors:  Ryan L Sheppard; Espen E Spangenburg; Eva R Chin; Stephen M Roth
Journal:  Physiol Genomics       Date:  2011-08-09       Impact factor: 3.107

5.  Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.

Authors:  Sean M Hartig; Bin He; Justin Y Newberg; Scott A Ochsner; David S Loose; Rainer B Lanz; Neil J McKenna; Benjamin M Buehrer; Sean E McGuire; Marco Marcelli; Michael A Mancini
Journal:  Chem Biol       Date:  2012-09-21

Review 6.  Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.

Authors:  Robert A Frost; Charles H Lang
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-10       Impact factor: 4.741

7.  7α-methyl-19-nortestosterone vs. testosterone implants for hypogonadal osteoporosis: a preclinical study in the aged male orchidectomized rat model.

Authors:  M Sinnesael; F Callewaert; M Morreels; N Kumar; R Sitruk-Ware; K Van Proeyen; P Hespel; S Boonen; F Claessens; D Vanderschueren
Journal:  Int J Androl       Date:  2011-07-26

8.  Reversal of muscle atrophy by Zhimu and Huangbai herb pair via activation of IGF-1/Akt and autophagy signal in cancer cachexia.

Authors:  Pengwei Zhuang; Jinbao Zhang; Yan Wang; Mixia Zhang; Lili Song; Zhiqiang Lu; Lu Zhang; Fengqi Zhang; Jing Wang; Yanjun Zhang; Hongjun Wei; Hongyan Li
Journal:  Support Care Cancer       Date:  2015-08-18       Impact factor: 3.603

9.  MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling.

Authors:  Jae-Sung Yi; Jun Sub Park; Young-Mi Ham; Nga Nguyen; Na-Rae Lee; Jin Hong; Bong-Woo Kim; Hyun Lee; Chang-Seok Lee; Byung-Cheon Jeong; Hyun Kyu Song; Hana Cho; Yoon Ki Kim; Jae-Seon Lee; Kyong Soo Park; Haksub Shin; Inho Choi; Seung Hee Lee; Woo Jin Park; Shi-Young Park; Cheol Soo Choi; Peihui Lin; Malith Karunasiri; Tao Tan; Pu Duann; Hua Zhu; Jianjie Ma; Young-Gyu Ko
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Nonmyocytic androgen receptor regulates the sexually dimorphic development of the embryonic bulbocavernosus muscle.

Authors:  Lerrie Ann Ipulan; Kentaro Suzuki; Yuki Sakamoto; Aki Murashima; Yuuki Imai; Akiko Omori; Naomi Nakagata; Ryuichi Nishinakamura; Petr Valasek; Gen Yamada
Journal:  Endocrinology       Date:  2014-04-17       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.